We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CLGN market cap is 48.31M. The company's latest EPS is USD -0.6129 and P/E is -6.89.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 43k | 299k | 98k | 249k | 4k |
| Operating Income | -4.6M | -5.07M | -4.33M | -4.41M | -4.54M |
| Net Income | -4.38M | -4.69M | -4.2M | -4.21M | -4.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.32M | 6.14M | 15.64M | 299k | 10.96M |
| Operating Income | -7.63M | -5.6M | 65k | -17.1M | -7.51M |
| Net Income | -11.16M | -5.77M | 237k | -16.93M | -7.02M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 37.56M | 34.13M | 30.29M | 26.57M | 22.44M |
| Total Liabilities | 5.16M | 5.79M | 5.85M | 5.84M | 5.52M |
| Total Equity | 32.4M | 28.34M | 24.45M | 20.73M | 16.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.75M | 10.84M | 51.22M | 37.77M | 34.13M |
| Total Liabilities | 6.66M | 6.36M | 6.1M | 5.49M | 5.79M |
| Total Equity | 4.09M | 4.48M | 45.12M | 32.28M | 28.34M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -418k | -2.76M | -3.25M | -7.18M | -10.63M |
| Investing | -784k | -1.16M | -82k | -341k | -481k |
| Financing | 1.11M | 1.11M | 9k | 9k | 9k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.7M | -4.45M | 2.5M | -13.7M | -2.76M |
| Investing | -1.46M | -519k | -31.56M | 28.92M | -1.16M |
| Financing | 5.41M | 4.47M | 38.76M | 1.87M | 1.11M |
| Market Cap | 48.31M |
| Price to Earnings Ratio | -6.89 |
| Price to Sales Ratio | 4.41 |
| Price to Cash Ratio | 1.81 |
| Price to Book Ratio | 1.71 |
| Dividend Yield | - |
| Shares Outstanding | 11.45M |
| Average Volume (1 week) | 14.68k |
| Average Volume (1 Month) | 16.08k |
| 52 Week Change | -31.30% |
| 52 Week High | 6.75 |
| 52 Week Low | 3.24 |
| Spread (Intraday) | 14.41 (83.05%) |
| Company Name | CollPlant Biotechnologies Ltd |
| Address |
4 oppenheimer rehovot, center 7670104 |
| Website | https://www.collplant.com |
| Industry | real estate (6500) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
